Unknown PHASE4 INTERVENTIONAL 2-arm NCT00825773

A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions (EVOLUTION)

A Randomized Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus SirOlimus ELUting Stent With Non-Biodegradable Polymer in the Treatment of PatIents With de nOvo Coronary Artery LesioNs

Sponsor: JW Medical Systems Ltd

Conditions Cardiac Death Ischemia Myocardial Infarction

Interventions Percutaneous Transluminal Coronary Angioplasty

Updated 6 times since 2017 Last updated: Jan 22, 2009 Started: Oct 31, 2008 Primary completion: Apr 30, 2010 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00825773, this PHASE4 trial focuses on Cardiac Death and Ischemia and remains ongoing. Sponsored by JW Medical Systems Ltd, it has been updated 6 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

JW Medical Systems Ltd

Data source: JW Medical Systems Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China